DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trizivir (Abacavir / Lamivudine / Zidovudine) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Trizivir (Abacavir / Lamivudine / Zidovudine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (69)
     Drug Exposure During Pregnancy (15)Anaemia (8)Pallor (8)more >>

Cases resulting in a serious event (69)
     Drug Exposure During Pregnancy (15)Anaemia (8)Pallor (8)more >>

Cases resulting in death (6)
     Myocardial Infarction (4)Pneumonia (2)Rales (2)more >>

Cases resulting in life threatening events (4)
     Interstitial Lung Disease (2)Myocardial Infarction (2)Pneumonia (1)more >>

Cases resulting in hospitalization (31)
     Anaemia (7)Pallor (7)Pyrexia (6)more >>

Cases resulting in disability (6)
     Coronary Artery Disease (4)Accommodation Disorder (1)Visual Acuity Reduced (1)more >>

Cases resulting in other serious reactions (26)
     Abortion Spontaneous (6)Drug Exposure During Pregnancy (6)Intra-Uterine Death (5)more >>

Below is a sample of reports where side effects / adverse reactions may be related to Trizivir (Abacavir / Lamivudine / Zidovudine). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in 36 year old female receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 36 year old female

Adverse reactions / side effects: Pregnancy, Ultrasound Antenatal Screen Abnormal

Suspect drug(s):
Darunavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-10-11

Maraviroc
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-10-11

Nelfinavir
    Administration route: Oral
    Indication: HIV Infection
    End date: 2007-10-10

Ritonavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-10-11

Trizivir
    Administration route: Oral
    Indication: HIV Infection
    End date: 2007-10-10

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-10-11



Adverse event in male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a pharmacist from United States on 2007-10-25

Patient: male

Adverse reactions / side effects: Haemoglobin Decreased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Ribavirin
    Dosage: 600mg am 400mg pm po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2007-08-24
    End date: 2007-10-07

Trizivir
    Dosage: fixed dose bid po
    Administration route: Oral
    Indication: HIV Infection



Adverse event in 46 year old male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-15

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Coronary Artery Disease

Adverse event resulted in: disablity

Suspect drug(s):
Combivir
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Invirase
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Kaletra
    Indication: HIV Infection
    Start date: 2005-01-31

Norvir
    Indication: HIV Infection
    Start date: 2006-01-11

Trizivir
    Indication: HIV Infection
    Start date: 2005-09-21

Zerit
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25



Adverse event in 46 year old male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-09

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Coronary Artery Disease

Adverse event resulted in: disablity

Suspect drug(s):
Combivir
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Invirase
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Kaletra
    Indication: HIV Infection
    Start date: 2005-01-31

Norvir
    Indication: HIV Infection
    Start date: 2006-01-11

Trizivir
    Indication: HIV Infection
    Start date: 2005-09-21

Zerit
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25



Adverse event in 46 year old male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-09

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Coronary Artery Disease

Adverse event resulted in: disablity

Suspect drug(s):
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-11

Norvir
    Administration route: Oral
    Start date: 1998-12-30
    End date: 2004-10-25

Trizivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-09-21

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Other drugs received by patient: Zelitrex; Escitalopram; Seresta



Adverse event in receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-09

Patient:

Adverse reactions / side effects: Abortion Spontaneous

Suspect drug(s):
Efavirenz
    Dosage: daily dose:600mg
    Administration route: Oral

Efavirenz
    Dosage: text:600/300 mg
    Administration route: Oral

Epzicom
    Dosage: text:600/300 mg
    Administration route: Oral

Epzicom
    Dosage: text:600/300 mg
    Administration route: Oral

Trizivir
    Dosage: text:600/600/300
    Administration route: Oral
    Start date: 2007-05-30
    End date: 2007-06-18

Viracept
    Dosage: daily dose:2500meq
    Administration route: Oral
    Start date: 2007-05-30
    End date: 2007-06-18



Adverse event in 46 year old male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from France on 2007-10-05

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Coronary Artery Disease

Adverse event resulted in: disablity

Suspect drug(s):
Lamivudine + Zidovudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-11

Saquinavir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Stavudine
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Trizivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-09-21

Other drugs received by patient: Valacyclovir HCL; Oxazepam; Escitalopram Oxalate



Adverse event in 39 year old female receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-05

Patient: 39 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Spontaneous

Suspect drug(s):
Efavirenz
    Dosage: 600mg per day
    Administration route: Oral
    Indication: HIV Infection
    End date: 2007-05-20

Epzicom
    Dosage: 1tab per day
    Administration route: Oral
    Indication: HIV Infection
    End date: 2007-05-20

Nelfinavir
    Dosage: 2500mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-30
    End date: 2007-06-18

Trizivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2007-05-30
    End date: 2007-06-18



Adverse event in 46 year old male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a consumer/non-health professional from France on 2007-10-01

Patient: 46 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Cardiac Disorder

Adverse event resulted in: disablity

Suspect drug(s):
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31
    End date: 2005-09-21

Invirase
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Kaletra
    Dosage: 4tab twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-01-31

Norvir
    Dosage: 100mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2006-01-11

Trizivir
    Dosage: 1tab twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2005-09-21

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1998-12-30
    End date: 2004-10-25

Other drugs received by patient: Zelitrex; Escitalopram; Seresta



Adverse event in female receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-23

Patient: female, weighing 1.2 kg (2.6 pounds)

Adverse reactions / side effects: Premature Baby, Drug Exposure During Pregnancy

Suspect drug(s):
Trizivir (Abacavir / Lamivudine / Zidovudine)

Other drugs received by patient: Kaletra; Truvada



Adverse event in male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a physician from Botswana on 2007-07-20

Patient: male

Adverse reactions / side effects: Pneumonia, Sepsis, Pallor, Respiratory Distress

Adverse event resulted in: death

Suspect drug(s):
Nevirapine
    Dosage: 6mg single dose
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-06-16
    End date: 2007-06-16

Trizivir
    Dosage: 1tab twice per day
    Indication: Antiviral Prophylaxis
    Start date: 2007-04-13
    End date: 2007-06-17

Zidovudine
    Indication: Antiviral Prophylaxis
    Start date: 2007-06-16
    End date: 2007-06-16

Zidovudine
    Dosage: 4mgk twice per day
    Administration route: Oral
    Start date: 2007-06-16
    End date: 2007-06-16



Adverse event in receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a physician from Botswana on 2007-07-12

Patient: , weighing 2.9 kg (6.4 pounds)

Adverse reactions / side effects: Polydactyly, Drug Exposure During Pregnancy, Intra-Uterine Death

Suspect drug(s):
Trizivir
    Dosage: 750mg twice per day
    Indication: Antiviral Prophylaxis
    Start date: 2007-04-26
    End date: 2007-07-02

Zidovudine
    Indication: Antiviral Prophylaxis

Other drugs received by patient: Vitamin CAP; Ferrous Sulfate



Adverse event in 26 year old female receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a physician from Botswana on 2007-07-11

Patient: 26 year old female, weighing 72.5 kg (159.5 pounds)

Adverse reactions / side effects: Abdominal Pain, Polydactyly, Intra-Uterine Death

Suspect drug(s):
Trizivir
    Dosage: 750mg twice per day
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-04-26
    End date: 2007-07-02

Zidovudine
    Administration route: Oral
    Indication: Antiviral Prophylaxis

Other drugs received by patient: Vitamin CAP; Ferrous Sulfate



Adverse event in 49 year old male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a physician from Germany on 2007-07-11

Patient: 49 year old male, weighing 57.0 kg (125.4 pounds)

Adverse reactions / side effects: Anaemia, Bone Marrow Failure, Dizziness, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Amitriptyline HCL
    Dosage: 75mg twice per day
    Administration route: Oral
    Indication: Depression

Trizivir
    Dosage: 750mg twice per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-08-11
    End date: 2007-04-25

Other drugs received by patient: Viread; Quilonum Retard; Zopiclon; Pantozol



Adverse event in female receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-06

Patient: female, weighing 2.6 kg (5.7 pounds)

Adverse reactions / side effects: Pulmonary Hypertension, Drug Exposure During Pregnancy, Neonatal Aspiration

Adverse event resulted in: hospitalization

Suspect drug(s):
Trizivir (Abacavir / Lamivudine / Zidovudine)

Other drugs received by patient: Kaletra



Adverse event in female receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-02

Patient: female

Adverse reactions / side effects: HIV Antibody Positive, Acoustic Stimulation Tests Abnormal, Anastomotic Leak, Cyanosis, Pneumothorax, Tracheo-Oesophageal Fistula, Nasal Disorder, Apnoea, Oxygen Saturation Decreased, Respiration Abnormal, White Blood Cell Count Increased, Intestinal Malrotation, Nasal Congestion, Convulsion, Small Intestinal Obstruction, Echocardiogram Abnormal, Volvulus, Staphylococcal Infection, Choanal Atresia, Drug Exposure During Pregnancy, Mediastinitis, Pulmonary Malformation, Bradycardia

Adverse event resulted in: hospitalization

Suspect drug(s):
AZT
    Indication: HIV Infection

Trizivir
    Dosage: 2tab per day
    Indication: HIV Infection
    Start date: 2006-08-22



Adverse event in 32 year old female receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-02

Patient: 32 year old female

Adverse reactions / side effects: Caesarean Section, Respiratory Disorder, Drug Exposure During Pregnancy, Amniotic Fluid Index Abnormal, Polyhydramnios, Adverse Event, Uterine Contractions During Pregnancy

Adverse event resulted in: hospitalization

Suspect drug(s):
Trizivir (Abacavir / Lamivudine / Zidovudine)

Other drugs received by patient: Unknown Antiretroviral Treatment



Adverse event in 30 year old female receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a physician from Botswana on 2007-06-27

Patient: 30 year old female

Adverse reactions / side effects: Meconium Stain, Large FOR Dates Baby, Stillbirth, Cervicitis

Suspect drug(s):
Trizivir
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-04-10

Zidovudine
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-06-16

Other drugs received by patient: Ferrous Sulfate TAB; Folic Acid; Prostaglandin; Antibiotics



Adverse event in male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a physician from Botswana on 2007-06-27

Patient: male, weighing 3.2 kg (7.0 pounds)

Adverse reactions / side effects: Jaundice, Sepsis, Intercostal Retraction, Pallor

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Trizivir (Abacavir / Lamivudine / Zidovudine)

Other drugs received by patient: Gentamicin; Ampicillin; Zidovudine



Adverse event in male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a physician from Botswana on 2007-06-25

Patient: male

Adverse reactions / side effects: Jaundice, Premature Baby, Anaemia, Pallor, Respiratory Distress, Respiration Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Nevirapine
    Dosage: 6mg single dose
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-10
    End date: 2007-05-10

Trizivir
    Dosage: 1tab twice per day
    Indication: Antiviral Prophylaxis
    Start date: 2007-04-25

Zidovudine
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-10
    End date: 2007-05-10

Zidovudine
    Dosage: 4mgk twice per day
    Administration route: Oral



Adverse event in male receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a physician from Botswana on 2007-06-12

Patient: male, weighing 1.4 kg (3.1 pounds)

Adverse reactions / side effects: Jaundice, Pallor, Respiratory Distress, Respiration Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Nevirapine
    Dosage: 6mg single dose
    Administration route: Oral
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-10
    End date: 2007-05-10

Trizivir
    Dosage: 1tab twice per day
    Indication: Antiviral Prophylaxis
    Start date: 2007-04-25

Zidovudine
    Indication: Antiviral Prophylaxis
    Start date: 2007-05-10
    End date: 2007-05-10

Zidovudine
    Dosage: 4mgk twice per day
    Administration route: Oral



Adverse event in receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a individual with unspecified qualification on 2007-06-06

Patient:

Adverse reactions / side effects: Blood Triglycerides Increased

Suspect drug(s):
Combivir
    Indication: HIV Infection

Trizivir
    Indication: HIV Infection

Viramune
    Administration route: Oral
    Indication: HIV Infection



Adverse event in receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a individual with unspecified qualification on 2007-06-06

Patient:

Adverse reactions / side effects: Blood Lactate Dehydrogenase Increased

Suspect drug(s):
Combivir
    Indication: HIV Infection

Trizivir
    Indication: HIV Infection

Viramune
    Administration route: Oral
    Indication: HIV Infection



Adverse event in receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a individual with unspecified qualification on 2007-06-06

Patient:

Adverse reactions / side effects: Lipase Increased

Suspect drug(s):
Combivir
    Indication: HIV Infection

Trizivir
    Indication: HIV Infection

Viramune
    Administration route: Oral
    Indication: HIV Infection



Adverse event in receiving Trizivir (Abacavir / Lamivudine / Zidovudine)

Reported by a individual with unspecified qualification on 2007-06-05

Patient:

Adverse reactions / side effects: Lipase Increased

Suspect drug(s):
Trizivir
    Indication: HIV Infection

Viramune
    Administration route: Oral
    Indication: HIV Infection

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009